CONSTELLATION PHARMCETICLS I's ticker is CNST and the CUSIP is 210373106. A total of 103 filers reported holding CONSTELLATION PHARMCETICLS I in Q4 2019. The put-call ratio across all filers is 0.31 and the average weighting 2.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2020 | $917,000 | -48.4% | 45,238 | -23.5% | 0.02% | -29.2% |
Q2 2020 | $1,778,000 | +177.4% | 59,170 | +190.0% | 0.02% | -40.0% |
Q1 2020 | $641,000 | -83.3% | 20,404 | -74.9% | 0.04% | -57.0% |
Q4 2019 | $3,830,000 | +1602.2% | 81,300 | +142.7% | 0.09% | +830.0% |
Q3 2018 | $225,000 | – | 33,500 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Ponoi II Management, LLC | 1,574,229 | $45,338,000 | 33.03% |
Ponoi Management, LLC | 1,880,623 | $54,162,000 | 30.99% |
VR Adviser, LLC | 4,016,873 | $115,686,000 | 17.01% |
Column Group LLC | 2,626,631 | $75,647,000 | 6.86% |
COMMODORE CAPITAL LP | 423,708 | $12,203,000 | 6.64% |
GREAT POINT PARTNERS LLC | 1,024,800 | $29,514,000 | 4.79% |
Venrock Management V, LLC | 1,557,276 | $44,850,000 | 4.23% |
Ghost Tree Capital, LLC | 625,000 | $18,000,000 | 4.01% |
Euclidean Capital LLC | 554,325 | $15,965,000 | 3.38% |
REGENTS OF THE UNIVERSITY OF CALIFORNIA | 737,406 | $21,237,000 | 3.07% |